Company
Board Member
2024-06-30–present
David Scadden, M.D.
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Scadden, M.D.
The company reported in an 8-K filed October 15, 2025 that David Scadden, M.D. resigned as director, effective October 15, 2025. The company reported in an 8-K filed July 1, 2024 that David Scadden, M.D. was appointed director, effective June 30, 2024.
“On October 14, 2025, each of John Hohneker, M.D., Briggs Morrison, M.D. and David Scadden M.D. notified the Company of such director's decision to resign from the Company's board of directors (the "Board") and all committees thereof, effective October 15, 2025.”
“On June 26, 2024, the board of directors elected Marella Thorell and David Scadden, M.D. as directors of the Company, effective June 30, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2024-06-30–present
-
Organization not stated
Board Member
SEC 8-K
2024-06-30–2025-10-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: director
-
Executive change Appointed: director